Mereo BioPharma Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	36.22	40.99	69.8	57.41	68.15	127.49
Cash & Short-Term Investments	36.22	40.99	69.8	57.41	68.15	127.49
Cash Growth	-42.03%	-41.27%	21.57%	-15.76%	-46.54%	297.32%
Other Receivables	1.56	1.5	2.79	4.5	3.23	3.01
Total Trade Receivables	1.56	1.5	2.79	4.5	3.23	3.01
Other Current Assets	2.25	2.53	2.18	1.83	3.78	3.78
Total Current Assets	40.03	45.02	74.76	63.75	75.17	134.28
Net Property, Plant & Equipment	0.2	0.38	0.98	1.65	2.22	3.42
Other Intangible Assets	0.38	0.52	0.64	14.16	24.38	33.21
Total Assets	40.61	45.92	76.39	79.56	101.77	170.92
Accounts Payable	3.23	1.33	2.44	2.65	3.72	3.38
Accrued Expenses	2.05	2.03	4.07	5.46	5.43	5.17
Current Portion of Long-Term Debt	-	-	5.54	-	13.41	-
Current Portion of Leases	-	0.2	0.71	0.65	0.56	0.84
Other Current Liabilities	0.91	0.74	1.1	1.37	1.34	7.56
Total Current Liabilities	6.18	4.3	13.85	10.14	24.47	16.96
Long-Term Debt	-	-	-	4.99	-	19.45
Long-Term Leases	-	-	0.19	0.91	1.48	2.37
Other Long-Term Liabilities	0.38	0.7	1.39	0.76	0.16	13.16
Total Long-Term Liabilities	0.38	0.7	1.57	6.65	1.63	34.98
Total Liabilities	6.56	5	15.42	16.8	26.1	51.94
Common Stock	3.15	3.14	3.06	2.68	2.27	2.37
Treasury Stock	-	-	-	-1.24	-1.28	-1.54
Additional Paid-in Capital	551.02	549.62	539.64	523	475.51	520.11
Accumulated Other Comprehensive Income	-12.57	-10.82	-18.85	-0.41	-2.62	-0.46
Retained Earnings	-507.54	-501.02	-462.88	-461.26	-398.22	-401.5
Shareholders' Equity	34.05	40.92	60.97	62.77	75.66	118.98
Total Liabilities & Equity	40.61	45.92	76.39	79.56	101.77	170.92
Total Debt	-	0.2	6.43	6.54	15.45	22.66
Net Cash (Debt)	36.22	40.79	63.37	50.87	52.7	104.83
Net Cash Growth	-11.20%	-35.63%	24.57%	-3.47%	-49.73%	1285.75%
Net Cash Per Share	0.23	0.26	0.43	0.39	0.44	0.94
Book Value	34.05	40.92	60.97	62.77	75.66	118.98
Book Value Per Share	0.21	0.26	0.41	0.48	0.63	1.07
Tangible Book Value	33.67	40.4	60.33	48.6	51.28	85.77
Tangible Book Value Per Share	0.21	0.25	0.41	0.37	0.43	0.77

SEC Filings: 10-K · 10-Q